Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements

Gelijkaardige items

• Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices
  door: Dhruva, Sanket S., et al.
  Gepubliceerd in: (2017)
• Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death
  door: Lalani, Christina, et al.
  Gepubliceerd in: (2021)
• Assessment of Clinical Trial Evidence for High-Risk Cardiovascular Devices Approved Under the Food and Drug Administration Priority Review Program
  door: Jones, L. Camille, et al.
  Gepubliceerd in: (2018)
• Comparison of Priority vs Standard US Food and Drug Administration Premarket Approval Review for High-Risk Medical Devices
  door: Ong, Caroline, et al.
  Gepubliceerd in: (2020)
• Transparency and Dermatologic Device Approval by the US Food and Drug Administration
  door: Ezaldein, Harib H., et al.
  Gepubliceerd in: (2018)